LCTX   $0.89  5.95% Market Closed After Close 0.89 0.0

Lineage Cell Therapeutics Inc
Total Cash 38.50M
totalCashPerShare 0.204
EBITDA -21.40M
Total Debt 2.95M
quickRatio 2.536
currentRatio 2.644
Total Revenue 6.19M
debtToEquity 4.413
Revenue/Share 0.034
ROA -0.12859
ROE -0.35042998
grossProfits
freeCashflow -8.91M
operatingCashflow -22.02M
earningsGrowth
revenueGrowth -0.563
grossMargins 1.2607499
ebitdaMargins 0.0
operatingMargins -4.1669
profitMargins 0.0
enterpriseValue 120.24M
forwardPE -5.5499997
floatShares 146.34M
sharesOutstanding 188.84M
sharesShort 15.22M
sharesShortPriorMonth 15.82M
dateShortInterest
sharesPercentSharesOut 0.08%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.50%
Short Ratio help_outline 40.98%
shortPercentOfFloat 0.10%
impliedSharesOutstanding
bookValue 0.362
Price To Book help_outline 2.30
earningsQuarterlyGrowth
netIncomeToCommon -24.19M
trailingEps -0.13%
forwardEps -0.15%
enterpriseToEbitda -5.62
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.04 3Q 2024
institutionsCount 141
lastUpdated Oct. 16, 2024, 12:30 p.m.